Search results for "Vaccines"


 
Results 111 - 120 of about 436 for "Vaccines".
Sort by: Relevance | Newest | Oldest

Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare

A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021

Monkeypox: 5 key points

An expert panel convened by ACP and Annals of Internal Medicine provided five key takeaways about diagnosing and managing monkeypox.
https://immattersacp.org/archives/2022/11/monkeypox-5-key-points.htm
1 Nov 2022

Distribution plans, data on vaccines; NIH cautious on latest antibody treatment

The Advisory Committee on Immunization Practices chose clinicians and long-term care residents for priority vaccination, while ACP offered additional input on the topic. The NIH said that casirivimab plus imdevimab should not be standard of care, and the CDC offered recommendations on shortening quarantine.
https://immattersacp.org/weekly/archives/2020/12/08/1.htm
8 Dec 2020

OTC birth control pill, naloxone gain approval

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023

Research, news about COVID-19 vaccines, resources from ACP on flu vaccination

Results of vaccine trials were positive, but concerns arose about safety.
https://immattersacp.org/weekly/archives/2020/09/15/1.htm
15 Sep 2020

Research on COVID-19 vaccines' duration, reactions, prioritization

Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021

New COVID-19 boosters, DNA test for cancer risk OK’ed

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/11/new-covid-19-boosters-dna-test-for-cancer-risk-oked.htm
1 Nov 2023

Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data

Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021

Transforming health care to improve U.S. life expectancy

The sobering decline in U.S. life expectancy reaffirms the exigency of health care reform anchored in a proactive and comprehensive approach.
https://immattersacp.org/archives/2023/10/transforming-health-care-to-improve-us-life-expectancy.htm
1 Oct 2023

First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more

The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next